Patent ID: 11939349
Assignee: GALECTO BIOTECH AB
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 3:
4. The method for treatment of claim 1, wherein B1 is selected from a pyridinyl optionally substituted with a group independently selected from a Cl, Br, methyl, CF3, OCH3, N-(2-oxa)-6-azaspiro[3.3]heptanyl, OH, NH2, CONH2, —CONR24R25, wherein R24 and R25 together with the nitrogen may form a heterocycloalkyl, CN, ethynyl, pyrimidinyl, pyridinyl, tetrahydropyridinyl, pyrrolidinyl, oxazolyl, thiazolyl.